Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-002209
Filing Date
2025-01-14
Accepted
2025-01-14 17:06:05
Documents
47
Period of Report
2024-11-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 673353
2 ex10-1.htm EX-10.1 46159
3 ex10-2.htm EX-10.2 42616
4 ex31-1.htm EX-31.1 13652
5 ex31-2.htm EX-31.2 13683
6 ex32-1.htm EX-32.1 6951
7 ex32-2.htm EX-32.2 6847
  Complete submission text file 0001493152-25-002209.txt   3927406

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE bmra-20241130.xsd EX-101.SCH 21666
9 XBRL CALCULATION FILE bmra-20241130_cal.xml EX-101.CAL 43294
10 XBRL DEFINITION FILE bmra-20241130_def.xml EX-101.DEF 96461
11 XBRL LABEL FILE bmra-20241130_lab.xml EX-101.LAB 234588
12 XBRL PRESENTATION FILE bmra-20241130_pre.xml EX-101.PRE 176509
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 555592
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 25530131
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)